Identifying FDA-Approved Drugs that Upregulate Utrophin A as a Therapeutic Strategy for Duchenne Muscular Dystrophy
Crossref DOI link: https://doi.org/10.1007/978-1-0716-2772-3_26
Published Online: 2022-11-19
Published Print: 2023
Update policy: https://doi.org/10.1007/springer_crossmark_policy
PĂ©ladeau, Christine
Jasmin, Bernard J.
Text and Data Mining valid from 2022-11-19
Version of Record valid from 2022-11-19
Chapter History
First Online: 19 November 2022